Masaki Okamoto

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias

Masaki Okamoto, Tomoaki Hoshino, Yasuhiko Kitasato et al. · European Respiratory Journal · 2010 · 220 citations · Full text

Inflammation, Fibrosis, Autoimmune Disease +11

Interstitial pneumonia associated with autoimmune pancreatitis.

Tomoki Taniguchi, Minoru S.H. Ko, Shuji Seko et al. · PubMed · 2004 · 172 citations · Full text

Immunohematology, Immunodeficiencies, Immunology +22

Periostin, a Matricellular Protein, Plays a Role in the Induction of Chemokines in Pulmonary Fibrosis

Masaru Uchida, Hiroshi Shiraishi, Shoichiro Ohta et al. · American Journal of Respiratory Cell and Molecular Biology · 2012 · 171 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Lung Inflammation +22

Role of Proinflammatory Cytokines IL-18 and IL-1β in Bleomycin-Induced Lung Injury in Humans and Mice

Tomoaki Hoshino, Masaki Okamoto, Yuki Sakazaki et al. · American Journal of Respiratory Cell and Molecular Biology · 2009 · 162 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Immunotoxicology +20